Triple-negative breast cancer (TNBC), which is characterized by lack of estrogen receptor (ER) and progesterone receptor (PR) expression and lack of overexpression/amplification of human epidermal growth factor receptor 2 (HER2), is the most aggressive subtype of breast cancer with the least favorable outcomes. This evidence concerns the gene PGR and breast carcinoma.